Abstract:Few new therapeutics exist to target airway inflammation in mild-to-moderate asthma. Alveolar macrophages regulate airway inflammation by producing proresolving eicosanoids. We hypothesized that stimulation of the purinergic receptor P2X7 in macrophages from individuals with asthma produces eicosanoids associated with airway inflammation and resolution, and that these responses are predicted, in part, by P2X7 pore function. Study subjects were recruited in an Institutional Review Board (IRB)-approved study. Alveolar macrophages were recovered from bronchoalveolar lavage fluid following bronchoscopy. Purinergic receptor classification was performed using flow cytometry and fluorescent cell assay. Macrophages were stimulated in vitro and eicosanoids were measured via ELISA or enzyme immunoassay (EIA) in the presence and absence of P2X7-specific agonist [2'(3')-O-(4-Benzoylbenzoyl)adenosine-5'-triphosphate tri(triethylammonium) salt (Bz-ATP)] and antagonist (AZD9056). Functional P2X7 pore status was confirmed in a live cell assay using P2X7-specific agonists and antagonists. Alveolar macrophages produced increased quantities of the oxylipins lipoxin A4 (LXA4), resolvin D1 (RvD1), and 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE) following stimulation with Bz-ATP compared with vehicle controls, responses that were attenuated in the presence of the P2X7-selective antagonist, AZD9056. LXA4 and RvD1 production was greatest at 1 h, whereas 15(S)-HETE was maximally produced 24 h. Prostaglandin E-2 and resolvin E1 were minimally produced by P2X7 activation, indicating differential signaling pathways involved in eicosanoid production in alveolar macrophages derived from individuals with asthma. The early production of the proresolving eicosanoids, LXA4 and resolvin D1, is regulated by P2X7, whereas generation of the proinflammatory eicosanoid, 15(S)-HETE, is only partially regulated through P2X7 signaling and reaches maximal production after the peak in proresolving eicosanoids.NEW & NOTEWORTHY Alveolar macrophages obtained from individuals with asthma produce soluble lipid mediators in response to P2X7 purinergic receptor signaling. Proinflammatory mediators may contribute to asthma exacerbations but proresolving mediators may help with resolution of asthma loss of control. These specialized proresolving lipid mediators may serve as future potential therapeutics for asthma exacerbation resolution and recovery.

P2X7 Receptor Indirectly Regulates the JAM-A Protein Content via Modulation of GSK-3β

Effect of P2X7 Receptor Knockout on AQP-5 Expression of Type I Alveolar Epithelial Cells

Prolonged Activation Of P2x7r Leads To Alveolar Epithelial Type I Cell Death By Suppressing Wnt/Beta-Catenin Pathway

P2X7 RECEPTOR PLAYS A CRUCIAL ROLE IN LPS‐MEDIATED ACUTE LUNG INJURY

Post-translational regulation of PGC-1α modulates fibrotic repair.

Purinergic P2X7 receptor regulates lung surfactant secretion in a paracrine manner.

Extracellular Atp is A Danger Signal Activating P2x(7) Receptor in Lung Inflammation and Fibrosis

Purinergic P2X7 Receptor: A Pivotal Role in Surfactant Regulation?

Knockout Mice Reveal a Major Role for Alveolar Epithelial Type I Cells in Alveolar Fluid Clearance

P2X7 signaling influences the production of pro-resolving and pro-inflammatory lipid mediators in alveolar macrophages derived from individuals with asthma

P2X7 receptor signaling promotes inflammation in renal parenchymal cells suffering from ischemia-reperfusion injury

Troglitazone-activated PPARγ Inhibits LPS-induced Lung Alveolar Type II Epithelial Cells Injuries Via TNF-α

Overexpression of Dominant Negative Peroxisome Proliferator-Activated Receptor-Γ (pparγ) in Alveolar Type II Epithelial Cells Causes Inflammation and T-cell Suppression in the Lung.

Wnt3a Mitigates Acute Lung Injury by Reducing P2X7 Receptor-Mediated Alveolar Epithelial Type I Cell Death

Attenuation of Ventilation-Enhanced Epithelial–Mesenchymal Transition through the Phosphoinositide 3-Kinase-γ in a Murine Bleomycin-Induced Acute Lung Injury Model

Blockage of P2X7 attenuates acute lung injury in mice by inhibiting NLRP3 inflammasome

Macrophage Cx43 Is Necessary for Fibroblast Cytosolic Calcium and Lung Fibrosis After Injury

The P2X7 Receptor is a Master Regulator of Microparticle and Mitochondria Exchange in Mouse Microglia

P2X7 receptor knockout does not alter renal function or prevent angiotensin II-induced kidney injury in F344 rats

Region-specific role for Pten in maintenance of epithelial phenotype and integrity

The Profibrotic Effect of Downregulated Na,K‑ATPase Β1 Subunit in Alveolar Epithelial Cells During Lung Fibrosis.